World News

Carrier invests in pharma box

USA: Carrier Ventures, the investment arm of Carrier Global Corporation, has provided financial backing for Ember LifeSciences, a Californian innovator in the pharmaceutical cold chain industry.

Launched in 2022 as a healthcare-focused spinoff of Ember Technologies Inc, Ember LifeSciences has developed Ember Cube, a proprietary temperature control technology.

Described as the world’s first self-refrigerated, cloud-based shipping box, the Ember Cube employs built-in cellular radio and GPS to report location, temperature and humidity levels to the cloud for real-time tracking. 

The reusable and rechargeable shipping box features a refrigeration system to help ensure the safety of temperature-sensitive biologics while in transit. The innovation provides a sustainable alternative and utilises advanced technology, including a return-to-sender feature, to address the millions of pounds of annual packaging waste from the pharmaceutical cold chain that includes single-use shipping materials such as cardboard, extruded polystyrene foam and ice packs.

“Logistics failures within the biopharma industry result in roughly $35bn worth of pharmaceutical products not reaching the people who need them,” said Jennifer Anderson, Carrier’s senior vice president, strategy, business development & chief sustainability officer. “Ember LifeSciences offers highly complementary, disruptive next-generation technology and high-growth potential. Together, we can continue to advance the connected cold chain, build upon our Lynx digital platform and further strengthen Carrier’s position in this space.”

Related Articles

Back to top button